Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Immunology

Microbiology

Internal Medicine

Infectious Diseases

Show all topics

DOI

10.1016/s0140-6736(20)31604-4

License

CC-BY-NC-ND

Other Formats

PDF